DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
DCPH
Delisted
DCPH was delisted on the 10th of June, 2024.
161 hedge funds and large institutions have $2.18B invested in Deciphera Pharmaceuticals, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 64 increasing their positions, 54 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
13% less capital invested
Capital invested by funds: $2.51B → $2.18B (-$333M)
27% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 22
Holders
161
Holding in Top 10
7
Calls
$22.6M
Puts
$21.3M
Top Buyers
1 | +$18.1M | |
2 | +$11.5M | |
3 | +$11.1M | |
4 |
AllianceBernstein
Nashville,
Tennessee
|
+$9.84M |
5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$9.83M |
Top Sellers
1 | -$20.7M | |
2 | -$19.8M | |
3 | -$17.9M | |
4 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$14.9M |
5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$12.5M |